Riskpilot← Back to searchSign inGet full accessCECILIAB AB
ABActiveOrg 5567254015Kommendörsgatan 25General medical practice activities · NACE 8621Est. 20070 employees
Revenue 2024
SEK 128K
-1% vs 2023
EBITDA margin
-103.1%
-762% vs 2023
Equity ratio
83.3%
Financial strength
Net profit 2024
SEK 4K
-96% vs 2023
| Revenue | SEK 128K | -1% |
| EBITDA | SEK -132K | -762% |
| Net profit | SEK 4K | -96% |
| Total assets | SEK 1,4M | +1% |
| Equity | SEK 1,2M | +0% |
| Employees | 0 | — |
Legal name
CECILIAB AB
Org number
5567254015
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 mars 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva hälso-och sjukvård och därmed förenlig verksamhet ävensom handel med konst och antikviteter. Vidare skall bolaget bedriva förvaltning av lös eller fast egendom samt därmed förenlig verksamhet.
Address
Kommendörsgatan 25
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 249 | 424 | 347 | 129 | 128 |
| Staff expenses | — | — | −20 | −22 | −31 |
| EBITDA | 96 | 263 | 171 | −15 | −132 |
| Depreciation & amort. | −0 | −9 | −9 | −9 | −9 |
| EBIT | 96 | 254 | 162 | −24 | −141 |
| Net financials | 74 | 429 | 159 | 175 | 165 |
| Profit before tax | 171 | 563 | 241 | 150 | 24 |
| Tax | −53 | −78 | −60 | −43 | −20 |
| Net profit | 118 | 485 | 181 | 108 | 4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 429 | 1 047 | 1 299 | 1 376 | 1 386 |
| Equity | 377 | 862 | 1 042 | 1 150 | 1 154 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 52 | 65 | 56 | 26 | 32 |
| Total debt | 52 | 65 | 56 | 26 | 32 |
EBITDA margin
-103.1%
This company
15.8%
Market median
-753% vs market
20202024
Equity ratio
83.3%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CECILIAB AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cecilia Marianne Linde | Board of Directors | 0 companies |
| Ebba Cecilia Marianne Linde | Deputy Board Member | 0 companies |